![Peter Altman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Altman
Vorstandsvorsitzender bei
BIOCARDIA, INC.
Vermögen: 277 387 $ am 31.05.2026
Profil
Peter Alan Altman was the founder of CareDx, Inc., founded in 1998, where the title held was Director from 2003 to 2014.
Dr. Altman was the founder of Lumen Therapeutics, founded in 2004, where the title held was Chief Executive Officer from 2004 to 2005.
Dr. Altman is also the founder of Sinus Rhythm Technologies, Inc...
Dr. Altman is currently President, Chief Executive Officer & Director at BioCardia, Inc. since 2002.
Dr. Altman is Chief Executive Officer at BioCardia Lifesciences, Inc. Dr. Altman is Director at Oncocyclist Biotech since 2018.
Former jobs include President, Chief Executive Officer & Director at BioCardia, Inc. and Principal at Ventritex, Inc. Education includes a doctorate from the University of California, Berkeley, a doctorate from The University of California, San Francisco, and undergraduate and graduate degrees from Fu Foundation School of Engineering & Applied Science.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOCARDIA, INC. 2.62% | 09.06.2026 | 298’266 ( 2.62% ) | 277 387 $ | 31.05.2026 |
Aktive Positionen von Peter Altman
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOCARDIA, INC. | Vorstandsvorsitzender | 01.01.2002 |
Oncocyclist Biotech | Direktor/Vorstandsmitglied | 01.01.2018 |
BioCardia Lifesciences, Inc.
 BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Peter Altman
| Unternehmen | Position | Ende |
|---|---|---|
| CAREDX, INC. | Gründer | 01.01.2014 |
Lumen Therapeutics
 Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Vorstandsvorsitzender | 01.01.2005 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Vorstandsvorsitzender | - |
Ventritex, Inc.
 Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Corporate Officer/Principal | - |
Sinus Rhythm Technologies, Inc.
 Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Corporate Officer/Principal | - |
Ausbildung von Peter Altman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Ventritex, Inc.
Ventritex, Inc. Medical SpecialtiesHealth Technology Designs, develops and sells cadence implantable defibrilators | Health Technology |
CareDx, Inc.
 CareDx, Inc. Medical SpecialtiesHealth Technology Manufactures diagnostic test kits and provides related testing services | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinus Rhythm Technologies, Inc.
Sinus Rhythm Technologies, Inc. Medical SpecialtiesHealth Technology Develops devices for the prevention of atrial fibrillation | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
Lumen Therapeutics
Lumen Therapeutics Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Fu Foundation School of Engineering & Applied Science
 Fu Foundation School of Engineering & Applied Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioCardia, Inc.
 BioCardia, Inc. BiotechnologyHealth Technology Develops biotherapeutics for cardiovascular disease | Health Technology |
BioCardia Lifesciences, Inc.
BioCardia Lifesciences, Inc. BiotechnologyHealth Technology Develops therapeutics for cardiovascular diseases | Health Technology |
Oncocyclist Biotech |
